2.20
0.46%
0.01
Harvard Bioscience Inc Stock (HBIO) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
12.93%
24.51
|
28.15 | 25.36 | 28.76 | 29.98 |
Cost Of Revenue |
17.65%
9.74
|
11.83 | 10.64 | 12.09 | 11.63 |
Gross Profit |
9.51%
14.77
|
16.32 | 14.73 | 16.67 | 18.35 |
Operating Expenses
|
6.28%
17.05
|
16.04 | 15.66 | 15.88 | 16.60 |
Benefits Costs and Expenses |
0.89%
29.00
|
29.26 | 25.93 | 30.86 | 28.77 |
Costs And Expenses |
0.89%
29.00
|
29.26 | 25.93 | 30.86 | 28.77 |
Operating Income/Loss |
908.16%
-2.279
|
0.282 | -0.933 | 0.796 | 1.749 |
Nonoperating Income/Loss |
59.21%
-2.205
|
-1.385 | 0.371 | -2.894 | -0.542 |
Income/Loss From Continuing Operations Before Tax |
306.53%
-4.484
|
-1.103 | -0.562 | -2.098 | 1.207 |
Income Tax Expense/Benefit |
70.63%
0.21
|
0.715 | 0.677 | -1.118 | 0.585 |
Income/Loss From Continuing Operations After Tax |
158.20%
-4.694
|
-1.818 | -1.239 | -0.98 | 0.622 |
Net Income/Loss
|
158.20%
-4.694
|
-1.818 | -1.239 | -0.98 | 0.622 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
57,769%
43.40
|
0.075 | 42.69 | 42.35 | 42.12 |
Diluted Average Shares |
57,769%
43.40
|
0.075 | 42.69 | 42.35 | 42.78 |
Basic Earnings Per Share |
175.00%
-0.11
|
-0.04 | -0.03 | -0.02 | 0.01 |
Diluted Earnings Per Share |
175.00%
-0.11
|
-0.04 | -0.03 | -0.02 | 0.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):